Skip to main content
. 2012 Jan;340(1):11–18. doi: 10.1124/jpet.111.186858

TABLE 1.

Baseline MAP (mm Hg) and HR (bpm) values before and after pretreatment with different drugs that were administered before WIN55,212-2 or its vehicle

Values are means ± S.E.M.

Treatment n MAP
HR
Before After Before After
Vehicle + vehicle 6 115.0 ± 6.0 113.3 ± 5.0 395 ± 12 400 ± 12
Vehicle + 7.5 μg WIN55,212-2 6 111.3 ± 3.0 108.0 ± 5.0 375 ± 10 350 ± 11
Vehicle + 15 μg WIN55,212-2 8 113.3 ± 5.0 115.0 ± 3.0 370 ± 10 368 ± 17
Wortmannin + vehicle 5 112.0 ± 6.0 117.0 ± 6.0 356 ± 15 376 ± 15
Wortmannin + 7.5 μg WIN55,212-2 8 112.0 ± 6.0 111.0 ± 5.0 360 ± 11 380 ± 10
Wortmannin + 15 μg WIN55,212-2 8 111.3 ± 3.0 112.0 ± 3.0 375 ± 10 363 ± 13
PD98059 + vehicle 5 113.0 ± 4.0 110.0 ± 4.0 398 ± 16 390 ± 20
PD98059 + 15 μg WIN55,212-2 8 117.0 ± 6.0 115.0 ± 4.0 400 ± 12 410 ± 12